JW Asset Management, LLC holds a concentrated book of 21 stocks worth $319.9M as of Q2 2026 (disclosed Aug 7, 2026, a ~38-day 13F lag). This quarter they opened Travere Therapeutics Inc and trimmed Establishment Labs Holdings. Their largest long position is Establishment Labs Holdings at 72% of the equity book. Cloning the disclosed picks since 2024 would be +64% (+32.9%/yr). That is a simulation of the disclosed long book, not audited returns.
Growth of $10,000 cloning JW Asset Management, LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~38 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
99% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Establishment Labs Hldgs Inc COM | $231.1M | 2.69M | 72.2% | ▼−12% Reduced · −369K sh | |
| 2 | Sandisk Corp COM | $17.8M | 7.8K | 5.6% | ▲+20% Added · +1K sh | |
| 3 | Vita Coco Co Inc COM | $14.5M | 218.6K | 4.5% | —Held | |
| 4 | Catalyst Pharmaceuticals Inc COM | $12.2M | 388.4K | 3.8% | —Held | |
| 5 | Micron Technology Inc COM | $8.1M | 7.0K | 2.5% | —Held | |
| 6 | Iren Limited ORDINARY SHARES | $6.6M | 144.7K | 2.1% | ▼−12% Reduced · −20K sh | |
| 7 | Idaho Strategic Resources COM NEW | $4.6M | 141.2K | 1.4% | ▼−1.4% Reduced · −2K sh | |
| 8 | Ralph Lauren Corp CL A | $4.0M | 10.0K | 1.3% | —Held | |
| 9 | Cava Group Inc COM | $3.9M | 50.0K | 1.2% | —Held | |
| 10 | Nvidia Corporation COM | $3.1M | 15.3K | 1.0% | —Held | |
| 11 | On Hldg AG NAMEN AKT A | $2.6M | 73.0K | 0.8% | ▼−12% Reduced · −10K sh | |
| 12 | Five Below Inc COM | $1.8M | 10.0K | 0.6% | —Held | |
| 13 | Travere Therapeutics Inc COM | $1.7M | 30.0K | 0.5% | ▲New New position | |
| 14 | Heron Therapeutics Inc COM | $1.6M | 3.75M | 0.5% | —Held | |
| 15 | Dell Technologies Inc CL C | $1.5M | 3.5K | 0.5% | ▲New New position | |
| 16 | Ligand Pharmaceuticals Inc COM NEW | $1.3M | 4.0K | 0.4% | ▲New New position | |
| 17 | Marvell Technology Inc COM | $953K | 3.2K | 0.3% | ▲New New position | |
| 18 | Trulieve Cannabis Corp SUB VTG SHS | $824K | 83.9K | 0.3% | ▲New New position | |
| 19 | Liquidia Corporation COM NEW | $811K | 10.2K | 0.3% | ▼−37% Reduced · −6K sh | |
| 20 | Advisorshares TR PURE US CANN ETF | $787K | 155.0K | 0.2% | ▲+94% Added · +75K sh | |
| 21 | High Tide Inc COM NEW | $220K | 96.6K | 0.1% | ▼−5.4% Reduced · −6K sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1549738/holdings"
Use Arkolith to show JW Asset Management, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 | 21 | $319.9M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 8, 2026 | 19 | $243.5M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 6, 2026 | 18 | $307.2M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 7, 2025 | 17 | $208.4M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 | 19 | $202.9M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 9, 2025 | 18 | $176.6M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 7, 2025 | 17 | $210.4M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 8, 2024 | 13 | $221.5M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.